A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicin

Juhani U. Maenpaa, Gregory T. Wurz, W. Jeffrey Baker, Valerie J. Wiebe, Vernon D. Emshoff, Steven K. Koester, Robert C. Seymour, R. Ellen Koehler, Michael W. DeGregorio

Research output: Contribution to journalArticle

2 Scopus citations

Fingerprint Dive into the research topics of 'A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicin'. Together they form a unique fingerprint.

Medicine & Life Sciences